Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Historical Holders from Q4 2020 to Q3 2025

Symbol
IMNM on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
110,897,279
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
91,384,562
Holdings value
$1,070,118,014
% of all portfolios
0.003%
Number of holders
153
Number of buys
89
Number of sells
-53
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +1.1% $152,894,064 +$80,670,694 13,056,709 +1.1% FMR LLC 30 Sep 2025
T. Rowe Price Investment Management, Inc. 12.2% $124,649,133 10,644,674 T. Rowe Price Investment Management, Inc. 31 Oct 2025
Redmile Group, LLC 6.2% $45,677,313 5,361,187 Redmile Group, LLC 31 Mar 2025
Point72 Asset Management, L.P. 5.9% $41,638,177 4,887,110 Point72 Asset Management, L.P. 31 Jan 2025
Immunome Aggregator, LP 6% $40,628,327 4,768,583 Immunome Aggregator, LP 31 Jan 2025
Enavate Sciences GP, LLC 4.3% $73,483,864 4,768,583 Enavate Sciences GP, LLC 18 Dec 2025
VANGUARD GROUP INC 5.2% +7.8% $42,082,054 +$14,150,080 4,524,952 +50.7% The Vanguard Group 30 Jun 2025
EcoR1 Capital, LLC 4.7% $34,756,616 4,079,415 EcoR1 Capital, LLC 31 Mar 2025
JANUS HENDERSON GROUP PLC 2.2% -55% $16,313,738 -$13,130,862 1,914,758 -44.6% JANUS HENDERSON GROUP PLC 31 Mar 2025

Institutional Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 91,384,562 $1,070,118,014 +$140,282,314 $11.71 153
2025 Q2 79,431,966 $738,692,421 +$30,839,753 $9.3 142
2025 Q1 76,944,016 $518,447,649 +$156,654,047 $6.73 141
2024 Q4 53,313,664 $566,321,086 -$37,080,544 $10.62 119
2024 Q3 51,629,246 $754,701,793 +$58,776,153 $14.62 114
2024 Q2 47,779,242 $578,110,445 +$106,966,991 $12.1 112
2024 Q1 36,616,859 $903,617,775 +$377,900,927 $24.68 102
2023 Q4 21,490,560 $229,948,765 +$205,035,908 $10.7 57
2023 Q3 2,729,076 $22,706,803 +$3,521,335 $8.35 36
2023 Q2 1,949,082 $15,421,801 +$698,301 $7.91 35
2023 Q1 1,860,095 $9,343,739 -$1,198,225 $4.99 30
2022 Q4 2,100,648 $4,845,087 -$694,148 $2.21 28
2022 Q3 2,300,040 $10,208,297 -$14,594 $4.43 23
2022 Q2 2,313,613 $7,426,000 -$1,197,731 $3.21 24
2022 Q1 2,694,238 $15,433,000 -$858,955 $5.68 26
2021 Q4 2,790,928 $36,364,000 +$4,810,967 $12.96 28
2021 Q3 2,391,433 $58,321,000 +$6,054,335 $24.35 31
2021 Q2 2,376,109 $41,107,000 +$6,432,363 $17.3 25
2021 Q1 1,909,240 $64,673,000 +$1,324,022 $33.86 30
2020 Q4 2,013,500 $19,489,000 +$19,489,000 $9.68 24